Morgan Stanley resumed coverage on Centene with a new price target
$CNC
Medical Specialities
Health Care
Morgan Stanley resumed coverage of Centene with a rating of Overweight and set a new price target of $70.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/9/2025 | $70.00 | Overweight | Morgan Stanley |
| 6/2/2025 | $65.00 | Overweight → Equal Weight | Barclays |
| 4/8/2025 | $64.00 | Underperform → Hold | Jefferies |
| 2/6/2025 | Buy → Hold | Argus | |
| 12/17/2024 | $80.00 → $75.00 | Overweight | Analyst |
| 12/13/2024 | $79.00 → $80.00 | Neutral → Buy | UBS |
| 12/10/2024 | $68.00 → $52.00 | Hold → Underperform | Jefferies |
| 7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies |
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)